Edition:
United Kingdom

Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

11.25USD
23 Apr 2018
Change (% chg)

$0.15 (+1.35%)
Prev Close
$11.10
Open
$11.20
Day's High
$11.40
Day's Low
$11.07
Volume
66,746
Avg. Vol
74,919
52-wk High
$13.60
52-wk Low
$3.95

Latest Key Developments (Source: Significant Developments)

Codexis Announces Proposed Public Offering Of Common Stock
Thursday, 5 Apr 2018 

April 6 (Reuters) - Codexis Inc ::CODEXIS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Telemark Asset Management LLC reports 6.72 pct passive stake in Codexis ‍​as of Nov 10
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Codexis Inc :Telemark Asset Management LLC reports 6.72 percent passive stake in Codexis Inc ‍​as of November 10 - SEC Filing.  Full Article

Codexis Q3 non-gaap loss per share $0.17
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Codexis Inc ::Codexis reports financial results for the third quarter of 2017.Q3 non-gaap loss per share $0.17.Q3 loss per share $0.21.Sees FY 2017 revenue $50 million to $53 million.Q3 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S.Codexis Inc - ‍total revenues for Q3 of 2017 were $10.0 million compared with $14.9 million for q3 of 2016​.Codexis Inc - ‍gross margin on product sales is expected to be between 40% and 43% for 2017​.  Full Article

Codexis Inc, Nestlé Health Science enter strategic collaboration​
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Codexis Inc :Codexis Inc - ‍co, Nestlé Health Science enter strategic collaboration​.Codexis Inc - ‍Codexis receives an upfront payment of $14 million and potential milestones and royalties depending on product success for deal​.Codexis Inc - deal ‍includes an option for global development of CDX-6114 for PKU​.Codexis Inc - ‍Codexis will be responsible for clinical development costs for CDX-6114 up to and including Phase 1 in healthy volunteers​.Codexis - after ‍phase 1, Nestlé health science will have option to obtain exclusive global license to CDX-6114.Codexis - after ‍Phase 1, Nestlé health science will be responsible for all future development and commercialization of CDX-6114​.  Full Article

Codexis files for mixed shelf of up to $80 million
Friday, 9 Dec 2016 

Codexis Inc :Files for mixed shelf of up to $80 million - sec filing.  Full Article

Codexis reports Q2 adj. earnings per share $0.12
Tuesday, 9 Aug 2016 

Codexis Inc : Codexis reports financial results for the second quarter of 2016 . Q2 earnings per share $0.05 . Sees FY 2016 revenue $46 million to $49 million . Q2 non-GAAP earnings per share $0.12 . Q2 earnings per share view $0.03 -- Thomson Reuters I/B/E/S .Q2 revenue $16 million versus I/B/E/S view $15.1 million.  Full Article

Codexis reports Q1 loss per share $0.17
Monday, 9 May 2016 

Codexis Inc : Codexis reports financial results for the first quarter of 2016 . Q1 non-GAAP loss per share $0.11 . Q1 loss per share $0.17 . Q1 revenue $8.0 million versus I/B/E/S view $7.5 million .Q1 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S.  Full Article